tenofovir has been researched along with Stillbirth in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Clark, R; Desmond, AC; Govender, V; Gray, G; Lombard, C; Mhlongo, O; Moodley, D; Naidoo, K; Naidoo, M; Newell, ML; Rooney, JF; Sebitloane, M | 1 |
Diseko, M; Essex, M; Jacobson, DL; Lockman, S; Makhema, J; Mayondi, G; Mmalane, M; Petlo, C; Rough, K; Shapiro, RL; Zash, R | 1 |
1 trial(s) available for tenofovir and Stillbirth
Article | Year |
---|---|
Pregnancy and neonatal safety outcomes of timing of initiation of daily oral tenofovir disoproxil fumarate and emtricitabine pre-exposure prophylaxis for HIV prevention (CAP016): an open-label, randomised, non-inferiority trial.
Topics: Adenine; Anti-HIV Agents; Birth Weight; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Pre-Exposure Prophylaxis; Pregnancy; Premature Birth; South Africa; Stillbirth; Tenofovir; Treatment Outcome | 2023 |
1 other study(ies) available for tenofovir and Stillbirth
Article | Year |
---|---|
Effect of Gestational Age at Tenofovir-Emtricitabine-Efavirenz Initiation on Adverse Birth Outcomes in Botswana.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Botswana; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Female; Fetal Death; Gestational Age; HIV Infections; Humans; Infant, Low Birth Weight; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Stillbirth; Tenofovir | 2018 |